| 证券代码：301188 | 证券简称：力诺药包 | 公告编号：2025-083 | | --- | --- | --- | | 债券代码：123221 | 债券简称：力诺转债 | | 山东力诺医药包装股份有限公司 关于力诺转债回售的第一次提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 1、债券简称：力诺转债 2、债券代码：123221 3、回售价格：100.055 元/张（含息、税） 4、回售申报期：2025 年 9 月 12 日至 2025 年 9 月 18 日 5、发行人资金到账日：2025 年 9 月 23 日 6、回售款划拨日：2025 年 9 月 24 日 7、投资者回售款到账日：2025 年 9 月 25 日 8、回售申报期内"力诺转债"暂停转股 东力诺特种玻璃股份有限公司创业板向不特定对象发行可转换公司债券募集说明 书》（以下简称"《募集说明书》"）约定，"力诺转债"的附加回售条款生效。 现将"力诺转债"回售有关事项公告如下： 一、回售情况概述 （一）触发回售的原因 2025 年 8 月 19 日，公司召开第四届董事会第十二次会议 ...

北京市中伦律师事务所 关于山东力诺医药包装股份有限公司 可转换公司债券回售的 法律意见书 二〇二五年九月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 法律意见书 北京市中伦律师事务所 关于山东力诺医药包装股份有限公司 可转换公司债券回售的 法律意见书 致：山东力诺医药包装股份有限公司 2 法律意见书 北京市中伦律师事务所（以下简称"本所"）是在中华人民共和国境内执业 的专业法律服务机构。本所接受山东力诺医药包装股份有限公司（曾用名"山东 力诺特种玻璃股份有限公司"，以下简称"力诺药包""发行人"或 ...

Group 1 - JinkoSolar's subsidiary plans to sell 80% stake in Jinko New Materials for 80 million yuan, which will no longer be included in JinkoSolar's consolidated financial statements [1] - Zhongtai Automobile's subsidiary has been forced to dismantle its T300 vehicle assembly line, making it unable to resume production this year, leading to uncertainty in its ongoing operational capacity [1] - Springlight Technology's shareholders plan to reduce their holdings by a total of 0.68% of the company's shares between October 9, 2025, and January 8, 2026 [2] Group 2 - Sentech's energy storage and charging integration business is in the expansion phase, with its main business focusing on building-integrated photovoltaics (BIPV) and environmental remediation [3] - Qinchuan IoT plans to reduce its holdings by up to 1% of the company's shares from October 9, 2025, to January 8, 2026, with proceeds to be used for working capital [4] - Redick's shareholder plans to reduce holdings by up to 2% of the company's shares starting from September 9, 2025 [5] Group 3 - Guangxun Technology plans to raise up to 3.5 billion yuan through a private placement to fund various projects, including optical connection and high-speed optical transmission product production [8] - Shanghai Electric has terminated its acquisition of K-Electric Limited, which was planned for 1.773 billion USD, and is now focusing on investing in offshore photovoltaic and wind power projects [9][10] - Longsoft Technology's shareholder intends to transfer 1.72% of the company's shares through a non-public transfer [10] Group 4 - Amgen Pharmaceuticals' shareholders plan to reduce their holdings by a total of 6% of the company's shares between October 9, 2025, and January 8, 2026 [11] - Juhe Materials intends to acquire the blank mask business from SKE for approximately 35 million yuan to expand its semiconductor materials business [12] - Linuo Medical Packaging's shareholder plans to reduce holdings by up to 3% of the company's shares from October 9, 2025, to January 8, 2026 [13] Group 5 - Dongzhu Ecology plans to acquire 89.49% of Kairuixing Technology through a combination of share issuance and cash payment, aiming to enter the satellite communication and space information technology sector [14] - Dabeinong's controlling shareholder plans to reduce holdings by up to 1.99% of the company's shares starting from September 10, 2025 [15] - Tianji Technology is promoting the industrialization of lithium sulfide material preparation patents, currently in the early stages of development [16] Group 6 - Jing Shan Light Machine's subsidiary has secured a procurement order worth approximately 1.005 billion yuan from a leading lithium battery company [17] - Daheng Technology plans to establish a wholly-owned subsidiary with an investment of 600 million yuan to expand its semiconductor business [18]

Group 1 - The core point of the article is that Linuo Pharmaceutical Packaging (301188.SZ) announced a plan for a major shareholder to reduce its stake in the company [1] - The shareholder, Jinan Hongdao New Energy Partnership (Limited Partnership), intends to reduce its holdings by up to 6.9787 million shares, which represents 3% of the company's total share capital [1]

力诺药包公告，持股6.5243%的股东济南鸿道新能源合伙企业（有限合伙）计划于2025年10月9日至 2026年1月8日，通过集中竞价和大宗交易方式合计减持公司股份不超过697.87万股，占公司总股本 3.00%，其中集中竞价不超过232.62万股，占1%；大宗交易不超过465.25万股，占2%。 ...

其中，以集中竞价交易方式减持公司股份不超过2,326,234股，即不得超过公司总股本比例的1%(采取集 中竞价交易方式进行交易的，在任意连续九十个自然日内，减持股份的总数不得超过公司股份总数的 1%)；以大宗交易方式减持公司股份不超过4,652,468股，即不得超过公司总股本比例的2%(采取大宗交 易方式进行交易的，在任意连续九十个自然日内，减持股份的总数不得超过公司股份总数的2%)。 格隆汇9月9日丨力诺药包(301188.SZ)公布，持有公司股份15,177,000股(占公司总股本比例6.3490%，占 公司剔除回购专用证券账户中股份数量后总股本的6.5243%)的股东济南鸿道新能源合伙企业(有限合伙) 计划在力诺药包《关于持股5%以上股东股份减持计划的预披露公告》披露之日起15个交易日之后的3个 月内(2025年10月9日至2026年1月8日，法律法规禁止减持的期间除外)以集中竞价方式和大宗交易方式 合计减持公司股份不超过6,978,702股，占公司总股本3.00%(公司总股本以剔除公司回购股份后的股份数 量232,623,445股为计算依据，下同)。 ...

格隆汇9月9日丨力诺药包(301188.SZ)公布，持有公司股份15,177,000股(占公司总股本比例6.3490%，占 公司剔除回购专用证券账户中股份数量后总股本的6.5243%)的股东济南鸿道新能源合伙企业(有限合伙) 计划在力诺药包《关于持股5%以上股东股份减持计划的预披露公告》披露之日起15个交易日之后的3个 月内(2025年10月9日至2026年1月8日，法律法规禁止减持的期间除外)以集中竞价方式和大宗交易方式 合计减持公司股份不超过6,978,702股，占公司总股本3.00%(公司总股本以剔除公司回购股份后的股份数 量232,623,445股为计算依据，下同)。 其中，以集中竞价交易方式减持公司股份不超过2,326,234股，即不得超过公司总股本比例的1%(采取集 中竞价交易方式进行交易的，在任意连续九十个自然日内，减持股份的总数不得超过公司股份总数的 1%)；以大宗交易方式减持公司股份不超过4,652,468股，即不得超过公司总股本比例的2%(采取大宗交 易方式进行交易的，在任意连续九十个自然日内，减持股份的总数不得超过公司股份总数的2%)。 ...

| 证券代码：301188 | 证券简称：力诺药包 | 公告编号：2025-082 | | --- | --- | --- | | 债券代码：123221 | 债券简称：力诺转债 | | 山东力诺医药包装股份有限公司 关于持股 5%以上股东股份减持计划的预披露公告 持股 5%以上股东济南鸿道新能源合伙企业（有限合伙）保证向本公司提供 的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1. 持有山东力诺医药包装股份有限公司（以下简称："公司"、"力诺药 包"）股份 15,177,000 股（占公司总股本比例 6.3490%，占公司剔除回购专用证 券账户中股份数量后总股本的 6.5243%）的股东济南鸿道新能源合伙企业（有限 合伙）计划在力诺药包《关于持股 5%以上股东股份减持计划的预披露公告》（以 下简称"预披露公告"）披露之日起 15 个交易日之后的 3 个月内（2025 年 10 月 9 日至 2026 年 1 月 8 日，法律法规禁止减持的期间除外）以集中竞价方式和大宗 交易方式合计减持公司股份不超过 6,97 ...

Meeting Overview - The bondholders' meeting of Shandong Linuo Medical Packaging Co., Ltd. was held on September 5, 2025, at 14:00 in the company's conference room [1][2] - One bondholder with voting rights attended the meeting, representing 61,950 bonds, which is 1.53% of the total outstanding bonds of 4,056,337 [1] Voting Results - The proposal was approved with 61,950 bonds in favor, representing a total principal amount of 6,195,000 yuan, which accounted for 100% of the voting rights present [2] - There were no opposing or abstaining votes recorded [2] Legal Opinion - The meeting was witnessed by lawyers from Beijing Zhonglun Law Firm, who confirmed that the meeting's procedures and results complied with relevant laws and regulations, making the resolutions legally binding for all bondholders [2][3]

Group 1 - The company announced that its second extraordinary general meeting of shareholders in 2025 approved the proposal to change part of the fundraising purposes [2] - The company also approved the proposal to purchase liability insurance for directors, supervisors, and senior management [2]